Evidence map›Paper›PMID 19053323›Full record

ArticleChemical research in toxicology2008

Mapping DNA adducts of mitomycin C and decarbamoyl mitomycin C in cell lines using liquid chromatography/ electrospray tandem mass spectrometry.

Manuel M Paz, Sweta Ladwa, Elise Champeil, Yanfeng Liu, Sara Rockwell, Ernest K Boamah, Jill Bargonetti, John Callahan, John Roach, Maria Tomasz

Open access · greenAbstract read
In one paragraph

Article in Chemical research in toxicology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Structure andmBio · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Cellular Repair of DNA-DNA Cross-Links Induced by 1,2,3,4-Diepoxybutane.International journal of molecular sciences · 2017
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Manuel M PazDepartment of Chemistry, Hunter College, City University of New York, New York 10021, USA.
Sweta Ladwa
Elise Champeil
Yanfeng Liu
Sara Rockwell
Ernest K Boamah
Jill Bargonetti
John Callahan
John Roach
Maria Tomasz
City University of New York · USHunter College · USUnited States Food and Drug Administration · USYale University · USJohn Jay College of Criminal Justice · US

Funding

WILD TYPE &MUTANT P53 INTERACTIONS WITH HIV LTR DNAG12RR003037 · NCRR · HUNTER COLLEGE · PI DOTTIN, ROBERT P · 1985 to 2011
$27.6M
RISE Program Hunter College Option IIIR25GM060665 · NIGMS · HUNTER COLLEGE · PI ORTIZ, BENJAMIN D.,, SERRANO, PETER A · 2000 to 2022
$22.8M
UBIQUITINATED PROTEIN DEGRADATION AND NEURODEGENERATIONS06GM060654 · NIGMS · HUNTER COLLEGE · PI LUINE, VICTORIA N · 2000 to 2011
$21.2M
TUMOR SELECTIVE INACTIVATION OF THE REPAIR PROTEIN AGTP01CA129186 · NCI · YALE UNIVERSITY · PI SARTORELLI, ALAN CLAYTON · 2007 to 2012
$8.5M
p53-Independent Cell Death Signaling by Mitomycin DNA AdductsSC1CA137843 · NCI · HUNTER COLLEGE · PI BARGONETTI, JILL E. · 2008 to 2011
$1.3M
ADDUCTS OF MITOMYCIN C WITH NUCLEOTIDESR01CA028681 · NCI · HUNTER COLLEGE · PI TOMASZ, MARIA · 1985 to 2006
$919k
ADDUCTS OF MITOMYCIN C WITH NUCLEOTIDESR37CA028681 · NCI · HUNTER COLLEGE · PI TOMASZ, MARIA · 1988 to 1996
–
NCI NIH HHS CA129186NCI NIH HHS CA28681NCI NIH HHS P01 CA129186NCI NIH HHS R01 CA028681NCI NIH HHS SC1 CA137843NCRR NIH HHS G12 RR003037NCRR NIH HHS RR03037NIGMS NIH HHS GM60665NIGMS NIH HHS R25 GM060665NIGMS NIH HHS S06 GM060654NIGMS NIH HHS S06 GM60654
6 · The paper itself

Abstract

The antitumor antibiotic and cancer chemotherapeutic agent mitomycin C (MC) alkylates and crosslinks DNA, forming six major MC-deoxyguanosine adducts of known structures in vitro and in vivo. Two of these adducts are derived from 2,7-diaminomitosene (2,7-DAM), a nontoxic reductive metabolite of MC formed in cells in situ. Several methods have been used for the analysis of MC-DNA adducts in the past; however, a need exists for a safer, more comprehensive and direct assay of the six-adduct complex. Development of an assay, based on mass spectrometry, is described. DNA from EMT6 mouse mammary tumor cells, Fanconi Anemia-A fibroblasts, normal human fibroblasts, and MCF-7 human breast cancer cells was isolated after MC or 10-decarbamoyl mitomycin C (DMC) treatment of the cells, digested to nucleosides, and submitted to liquid chromatography electrospray-tandem mass spectrometry. Two fragments of each parent ion were monitored ("multiple reaction monitoring"). Identification and quantitative analysis were based on a standard mixture of six adducts, the preparation of which is described here in detail. The lower limit of detection of adducts is estimated as 0.25 pmol. Three initial applications of this method are reported as follows: (i) differential kinetics of adduct repair in EMT6 cells, (ii) analysis of adducts in MC- or DMC-treated Fanconi Anemia cells, and (iii) comparison of the adducts generated by treatment of MCF-7 breast cancer cells with MC and DMC. Notable results are the following: Repair removal of the DNA interstrand cross-link and of the two adducts of 2,7-DAM is relatively slow; both MC and DMC generate DNA interstrand cross-links in human fibroblasts, Fanconi Anemia-A fibroblasts, and MCF-7 cells as well as EMT6 cells; and DMC shows a stereochemical preference of linkage to the guanine-2-amino group opposite from that of MC.

Indexed as

AnimalsBreast NeoplasmsCell Line, TumorChromatography, High Pressure LiquidCross-Linking ReagentsDNA AdductsDNA DamageDNA, NeoplasmDNA RepairFibroblastsHumansMammary Neoplasms, AnimalMiceMitomycinMitomycinsSpectrometry, Mass, Electrospray Ionization10-decarbamoylmitomycin CCross-Linking ReagentsDNA AdductsDNA, NeoplasmMitomycinMitomycins

Identifiers

PMID19053323
PMCPMC2630229
OpenAlexW2025568952

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.